Header Logo

Johanna Seddon

Concepts (703)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Macular Degeneration
128
2025
179
30.520
Why?
Polymorphism, Single Nucleotide
44
2022
454
7.460
Why?
Genetic Predisposition to Disease
45
2022
677
6.200
Why?
Complement Factor H
26
2025
148
4.910
Why?
Retinal Drusen
15
2022
16
4.620
Why?
Choroidal Neovascularization
13
2020
29
4.300
Why?
Genetic Variation
22
2020
367
3.450
Why?
Geographic Atrophy
9
2018
20
3.270
Why?
Tomography, Optical Coherence
10
2024
208
3.240
Why?
Disease Progression
33
2024
1054
2.830
Why?
Genotype
40
2021
643
2.780
Why?
Proteins
16
2020
743
2.730
Why?
Risk Factors
102
2023
5082
2.700
Why?
Choroid
7
2020
26
2.560
Why?
Aged
149
2024
13581
2.400
Why?
Complement Factor I
7
2022
9
2.260
Why?
Visual Acuity
26
2024
118
2.240
Why?
Wet Macular Degeneration
5
2017
26
2.150
Why?
Smoking
22
2020
835
2.010
Why?
Male
167
2025
27971
1.930
Why?
Aged, 80 and over
68
2024
5197
1.910
Why?
Humans
255
2025
60132
1.900
Why?
Female
170
2025
31250
1.850
Why?
Phenotype
21
2019
1158
1.790
Why?
Melanoma
53
2021
335
1.710
Why?
Retinoblastoma
18
2021
27
1.690
Why?
Follow-Up Studies
50
2024
2362
1.660
Why?
Middle Aged
143
2024
16535
1.650
Why?
Complement C3
10
2020
61
1.630
Why?
Case-Control Studies
39
2021
1066
1.620
Why?
Uveal Neoplasms
41
1993
52
1.600
Why?
Aging
17
2020
731
1.600
Why?
High-Temperature Requirement A Serine Peptidase 1
8
2020
9
1.540
Why?
Diet
14
2024
637
1.530
Why?
Cataract
26
2016
54
1.530
Why?
Lipase
5
2011
49
1.480
Why?
Complement System Proteins
6
2021
127
1.430
Why?
Prospective Studies
45
2024
3131
1.420
Why?
Pedigree
15
2024
192
1.420
Why?
Dog Diseases
3
2021
54
1.410
Why?
Genome-Wide Association Study
10
2016
324
1.370
Why?
Retina
6
2023
119
1.360
Why?
Fluorescein Angiography
13
2024
58
1.340
Why?
Serine Endopeptidases
5
2016
82
1.280
Why?
Dogs
5
2021
307
1.260
Why?
Retinal Vessels
4
2016
18
1.210
Why?
Twins, Monozygotic
5
2014
70
1.210
Why?
Vitamins
8
2017
82
1.210
Why?
Diet, Mediterranean
2
2020
32
1.180
Why?
Body Mass Index
11
2020
892
1.160
Why?
Risk Assessment
11
2019
1937
1.130
Why?
Antioxidants
10
2016
248
1.130
Why?
Retinal Neoplasms
12
2021
16
1.080
Why?
Vascular Endothelial Growth Factor A
4
2020
200
1.060
Why?
Fatty Acids, Omega-3
6
2024
48
1.060
Why?
C-Reactive Protein
4
2010
168
1.000
Why?
Gene-Environment Interaction
2
2017
51
1.000
Why?
Longitudinal Studies
11
2024
1237
0.990
Why?
Incidence
30
2021
1265
0.970
Why?
Vitamin D
3
2017
149
0.970
Why?
Peripherins
1
2024
14
0.950
Why?
Life Style
5
2023
330
0.940
Why?
Mutation, Missense
4
2016
180
0.940
Why?
Retinal Pigment Epithelium
4
2025
31
0.920
Why?
Environment
5
2015
125
0.920
Why?
Macula Lutea
9
2015
21
0.910
Why?
Genetic Association Studies
5
2024
119
0.900
Why?
Diseases in Twins
4
2011
55
0.890
Why?
Alleles
11
2020
424
0.890
Why?
Cholesterol, HDL
4
2012
79
0.850
Why?
Dietary Fats
4
2013
204
0.810
Why?
Bruch Membrane
2
2025
7
0.780
Why?
Neoplasms, Second Primary
9
2021
41
0.780
Why?
Genetic Testing
2
2015
132
0.770
Why?
Quantitative Trait Loci
1
2021
71
0.740
Why?
Cohort Studies
23
2021
2479
0.730
Why?
Deafness
1
2021
33
0.730
Why?
Choroid Neoplasms
17
2005
22
0.700
Why?
Ciliary Arteries
1
2020
2
0.690
Why?
Models, Genetic
6
2021
253
0.690
Why?
Prevalence
15
2019
1300
0.680
Why?
Eye Diseases, Hereditary
2
2016
3
0.670
Why?
United States
42
2021
7622
0.660
Why?
Complement C2
7
2016
9
0.660
Why?
Vision Disorders
4
2018
59
0.650
Why?
Survivors
11
2019
148
0.650
Why?
Lutein
6
2024
24
0.650
Why?
Apolipoproteins E
5
2012
99
0.650
Why?
Gene Frequency
10
2015
129
0.650
Why?
Eye Proteins
5
2018
73
0.640
Why?
Biomarkers
5
2017
1213
0.630
Why?
Complement C9
2
2021
4
0.630
Why?
Haplotypes
7
2011
117
0.630
Why?
Blindness
3
2015
37
0.620
Why?
Angiogenesis Inhibitors
2
2017
78
0.620
Why?
ATP-Binding Cassette Transporters
3
2011
37
0.600
Why?
Chromosome Mapping
6
2016
293
0.590
Why?
Collagen Type VIII
2
2016
2
0.590
Why?
Complement Factor B
6
2016
11
0.580
Why?
Prognosis
19
2021
1591
0.580
Why?
Zinc
6
2008
91
0.570
Why?
Awards and Prizes
1
2017
30
0.570
Why?
Ophthalmology
1
2017
23
0.570
Why?
Macrophages
2
2020
1013
0.570
Why?
Algorithms
6
2023
1002
0.560
Why?
Eye Diseases
4
2013
37
0.560
Why?
Vitamin D Deficiency
1
2017
50
0.560
Why?
DNA
2
2024
793
0.560
Why?
Cataract Extraction
15
2009
35
0.550
Why?
Adult
80
2024
15985
0.550
Why?
Chymotrypsin
1
2016
27
0.540
Why?
Epigenomics
2
2014
54
0.540
Why?
Zinc Compounds
1
2016
7
0.530
Why?
Fibrinogen
2
2022
31
0.530
Why?
Heterozygote
7
2022
166
0.530
Why?
Vitamin B Complex
1
2016
22
0.520
Why?
Aspirin
5
2013
171
0.510
Why?
Homocysteine
2
2006
57
0.510
Why?
Folic Acid
1
2016
58
0.510
Why?
Fish Products
2
2006
6
0.490
Why?
Lod Score
4
2014
26
0.490
Why?
Cancer Survivors
3
2021
80
0.490
Why?
Inflammation
2
2020
1110
0.480
Why?
Ubiquitin-Protein Ligases
1
2016
207
0.480
Why?
Severity of Illness Index
6
2020
1471
0.460
Why?
Proportional Hazards Models
12
2013
679
0.460
Why?
Risk
15
2014
377
0.450
Why?
Exome
1
2014
73
0.450
Why?
Hearing Loss, Sensorineural
1
2014
46
0.450
Why?
Polymorphism, Genetic
4
2009
194
0.440
Why?
Women's Health
4
2016
390
0.440
Why?
Multivariate Analysis
12
2014
928
0.440
Why?
Diet Records
7
2017
47
0.440
Why?
Odds Ratio
10
2015
774
0.440
Why?
Dietary Supplements
8
2017
249
0.440
Why?
Amino Acid Substitution
4
2016
252
0.430
Why?
Optic Atrophy
1
2013
6
0.430
Why?
Environmental Exposure
2
2013
212
0.430
Why?
Genetic Linkage
4
2009
101
0.420
Why?
Mutation
7
2024
2471
0.420
Why?
Complement Pathway, Alternative
2
2011
27
0.420
Why?
Myopia
1
2012
2
0.410
Why?
Complement C1
1
2012
4
0.410
Why?
Twins, Dizygotic
3
2011
55
0.400
Why?
Models, Biological
4
2018
1143
0.390
Why?
Markov Chains
1
2012
37
0.390
Why?
Age of Onset
4
2020
171
0.390
Why?
Fundus Oculi
9
2016
21
0.390
Why?
Models, Theoretical
2
2013
258
0.390
Why?
Protons
19
1993
62
0.390
Why?
Minerals
2
2007
19
0.390
Why?
Demography
3
2023
178
0.390
Why?
Penetrance
1
2011
11
0.390
Why?
Tissue Inhibitor of Metalloproteinase-3
4
2020
5
0.390
Why?
Photography
9
2020
43
0.390
Why?
Anti-Inflammatory Agents, Non-Steroidal
2
2013
201
0.390
Why?
Neoplasms, Radiation-Induced
5
2019
26
0.380
Why?
Glaucoma, Open-Angle
2
2011
38
0.380
Why?
Optic Disk Drusen
1
2011
1
0.380
Why?
Collagen Type X
1
2011
4
0.380
Why?
Betaine
1
2011
10
0.370
Why?
DNA Mutational Analysis
4
2024
196
0.370
Why?
Methionine
1
2011
56
0.370
Why?
Albuminuria
1
2011
24
0.360
Why?
Rhipicephalus
1
2010
1
0.360
Why?
Acaricides
1
2010
1
0.360
Why?
Protein-Tyrosine Kinases
1
2011
113
0.360
Why?
Pyrethrins
1
2010
5
0.360
Why?
Sodium Channels
1
2010
20
0.350
Why?
Retrospective Studies
17
2016
6139
0.350
Why?
Survival Analysis
5
2016
558
0.350
Why?
Drug Resistance
1
2010
92
0.340
Why?
Animals
18
2025
19768
0.330
Why?
Surveys and Questionnaires
18
2011
2616
0.330
Why?
Kidney Diseases
1
2011
160
0.330
Why?
Neoplasm Proteins
1
2011
277
0.330
Why?
Skin Neoplasms
6
2021
405
0.320
Why?
Adolescent
31
2024
5958
0.320
Why?
Toll-Like Receptor 3
1
2009
67
0.320
Why?
Histocompatibility Antigens Class II
1
2009
179
0.310
Why?
Biological Evolution
1
2009
111
0.310
Why?
Time Factors
15
2016
3618
0.310
Why?
Breeding
2
2021
26
0.310
Why?
Sequence Analysis, DNA
4
2013
398
0.300
Why?
Point Mutation
3
2010
164
0.300
Why?
Australia
2
2021
95
0.300
Why?
DNA Methylation
3
2014
273
0.300
Why?
Eye Neoplasms
8
2014
17
0.290
Why?
Complement C3b
2
2020
20
0.290
Why?
Health Behavior
1
2011
472
0.290
Why?
DNA-Binding Proteins
1
2014
1136
0.290
Why?
Immunohistochemistry
3
2020
854
0.290
Why?
Reproducibility of Results
10
2016
1565
0.280
Why?
Estrogen Replacement Therapy
3
2007
86
0.280
Why?
Siblings
4
2012
45
0.280
Why?
Sarcoma
4
2019
36
0.280
Why?
Vegetables
2
2024
91
0.280
Why?
Cross-Sectional Studies
7
2016
2505
0.280
Why?
Ranibizumab
2
2017
20
0.270
Why?
Polycystic Kidney Diseases
1
2006
18
0.270
Why?
Carotenoids
8
2007
72
0.270
Why?
TRPP Cation Channels
1
2006
24
0.270
Why?
Nutritional Physiological Phenomena
3
2017
28
0.270
Why?
Intravitreal Injections
2
2017
49
0.270
Why?
Models, Statistical
5
2012
309
0.260
Why?
Energy Intake
6
2017
213
0.260
Why?
Linkage Disequilibrium
3
2011
46
0.260
Why?
Radiotherapy
6
2019
65
0.260
Why?
Diagnostic Techniques, Ophthalmological
1
2006
14
0.260
Why?
Polymerase Chain Reaction
3
2019
498
0.260
Why?
Young Adult
8
2024
4396
0.250
Why?
Hypertension
2
2011
603
0.250
Why?
Feeding Behavior
7
2008
314
0.250
Why?
Genome, Human
2
2005
219
0.240
Why?
Sensitivity and Specificity
4
2013
1100
0.240
Why?
Diabetes Mellitus
2
2009
538
0.240
Why?
Wolves
1
2004
3
0.240
Why?
Retinal Dystrophies
1
2024
4
0.240
Why?
Genetic Drift
1
2004
15
0.240
Why?
Genes, MHC Class II
1
2004
37
0.240
Why?
Chromosomes, Human
1
2005
54
0.240
Why?
Genetics, Population
1
2004
41
0.240
Why?
Activities of Daily Living
6
2000
301
0.230
Why?
Alcohol Drinking
6
2000
305
0.230
Why?
Gene Expression Regulation
2
2014
1539
0.230
Why?
Diabetes Mellitus, Type 2
1
2011
676
0.230
Why?
Child
14
2024
4336
0.230
Why?
Multimodal Imaging
1
2024
67
0.230
Why?
alpha 1-Antitrypsin
1
2025
88
0.230
Why?
Nuts
1
2003
7
0.220
Why?
Interleukin-6
1
2005
309
0.220
Why?
Body Constitution
1
2003
15
0.220
Why?
Nutritional Status
1
2024
119
0.220
Why?
United Kingdom
2
2021
70
0.220
Why?
Registries
6
2011
809
0.210
Why?
Glaucoma
5
2016
46
0.210
Why?
Ciliary Body
7
2000
11
0.210
Why?
Reproductive History
1
2002
15
0.210
Why?
Contraceptives, Oral, Hormonal
1
2002
18
0.210
Why?
Area Under Curve
2
2013
125
0.200
Why?
Dietary Fats, Unsaturated
3
2008
24
0.200
Why?
Fovea Centralis
3
1996
17
0.200
Why?
Diagnostic Self Evaluation
1
2022
23
0.200
Why?
Postmenopause
2
2006
246
0.200
Why?
Logistic Models
6
2014
1259
0.200
Why?
Cardiovascular Diseases
6
2007
832
0.200
Why?
Lipids
3
2010
307
0.200
Why?
Tissue Donors
2
2020
133
0.190
Why?
Vitamin A
5
2007
27
0.190
Why?
Microscopy, Confocal
2
2020
219
0.190
Why?
Ultraviolet Rays
3
2000
125
0.190
Why?
High-Throughput Nucleotide Sequencing
2
2014
261
0.190
Why?
Radiation Injuries
7
2009
62
0.190
Why?
Machine Learning
1
2023
150
0.180
Why?
Infant
12
2019
1531
0.180
Why?
Double-Blind Method
6
2016
680
0.180
Why?
Rehabilitation
1
2000
6
0.180
Why?
Vision, Low
1
2000
9
0.180
Why?
Health Risk Behaviors
1
2020
7
0.180
Why?
Genetic Markers
3
2012
122
0.180
Why?
HSP110 Heat-Shock Proteins
1
2020
1
0.180
Why?
Hormone Replacement Therapy
1
2000
30
0.180
Why?
Plant Lectins
1
2020
6
0.170
Why?
Age Factors
15
2019
1525
0.170
Why?
Survival Rate
9
2021
793
0.170
Why?
Molecular Epidemiology
2
2010
26
0.170
Why?
Staining and Labeling
3
2020
125
0.170
Why?
Geriatric Assessment
3
2015
165
0.160
Why?
Obesity
3
2007
1192
0.160
Why?
Intraocular Pressure
3
2005
60
0.160
Why?
Child, Preschool
11
2019
1851
0.160
Why?
Bone Neoplasms
2
2019
117
0.160
Why?
Retinal Diseases
4
1994
31
0.160
Why?
Endothelium, Vascular
1
2020
171
0.160
Why?
Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization
2
2008
82
0.150
Why?
Health Surveys
1
1999
311
0.150
Why?
Ascorbic Acid
5
2007
51
0.150
Why?
Public Health
2
2003
180
0.150
Why?
Vitamin E
5
2007
54
0.150
Why?
Pigment Epithelium of Eye
6
2009
12
0.140
Why?
Sequence Alignment
2
2010
292
0.140
Why?
Collagen Type IV
1
2016
3
0.140
Why?
Base Sequence
2
2013
1313
0.140
Why?
Nurses
3
2016
104
0.140
Why?
Riboflavin
2
2016
14
0.140
Why?
Predictive Value of Tests
5
2013
1035
0.140
Why?
False Positive Reactions
2
2013
74
0.130
Why?
Mastocytosis, Systemic
1
2016
6
0.130
Why?
Choroid Diseases
1
2016
5
0.130
Why?
Cell Degranulation
1
2016
20
0.130
Why?
Thiamine
1
2016
19
0.130
Why?
Microsatellite Repeats
2
2006
37
0.130
Why?
Regional Blood Flow
1
2016
108
0.130
Why?
Mast Cells
1
2016
41
0.130
Why?
Quality of Life
3
2008
1140
0.130
Why?
Autoantigens
1
2016
125
0.130
Why?
Retinal Degeneration
1
2016
28
0.130
Why?
Bevacizumab
1
2015
57
0.130
Why?
Regression Analysis
11
2010
486
0.120
Why?
Nuclear Proteins
1
2020
760
0.120
Why?
Equipment Design
1
2016
318
0.120
Why?
Retinoblastoma Protein
2
2012
37
0.120
Why?
Germ-Line Mutation
2
2012
47
0.120
Why?
Neovascularization, Pathologic
1
1996
138
0.120
Why?
Evoked Potentials, Auditory, Brain Stem
1
2014
8
0.120
Why?
Neuroglia
1
2015
79
0.120
Why?
Population Surveillance
3
2019
206
0.120
Why?
Immunity, Innate
1
2020
768
0.120
Why?
Computer Simulation
2
2009
458
0.120
Why?
Cholesterol, LDL
2
2010
105
0.120
Why?
Gliosis
1
2014
27
0.120
Why?
Retinal Vein
2
1998
5
0.110
Why?
Bestrophins
3
2003
3
0.110
Why?
Disease
1
2014
26
0.110
Why?
Eye Enucleation
7
1993
11
0.110
Why?
Molecular Sequence Data
2
2010
1983
0.110
Why?
DNA Copy Number Variations
1
2014
67
0.110
Why?
Leiomyosarcoma
2
2011
9
0.110
Why?
Brachytherapy
3
2009
41
0.110
Why?
Magnetic Resonance Spectroscopy
3
1990
292
0.110
Why?
Optic Disk
3
1993
24
0.110
Why?
Chloride Channels
3
2003
28
0.110
Why?
Diagnostic Tests, Routine
1
1994
40
0.110
Why?
Triglycerides
2
2010
242
0.110
Why?
Genotyping Techniques
1
2013
14
0.110
Why?
Eating
3
2007
139
0.110
Why?
Complement Activation
1
2013
53
0.110
Why?
Retinal Artery
1
1993
2
0.110
Why?
Oligonucleotide Array Sequence Analysis
2
2014
292
0.100
Why?
Patient Compliance
1
2015
372
0.100
Why?
Discriminant Analysis
1
2012
16
0.100
Why?
Electrooculography
2
2003
6
0.100
Why?
Nuclear Family
2
2003
19
0.100
Why?
Cobalt Radioisotopes
4
2009
5
0.100
Why?
Genetic Loci
1
2013
104
0.100
Why?
Nutrition Surveys
2
2011
154
0.100
Why?
Eye Color
2
2000
3
0.100
Why?
Massachusetts
7
2002
2118
0.100
Why?
Kinetics
1
2014
738
0.100
Why?
Skin
2
1992
356
0.100
Why?
Treatment Outcome
3
2015
5262
0.100
Why?
Principal Component Analysis
1
2011
60
0.100
Why?
ATP Binding Cassette Transporter 1
1
2011
10
0.090
Why?
Uterine Neoplasms
1
2011
31
0.090
Why?
Behavior
1
2011
37
0.090
Why?
Protein Conformation
1
2014
774
0.090
Why?
Anthropometry
1
2011
80
0.090
Why?
Observer Variation
3
2006
203
0.090
Why?
Iris
1
1990
3
0.090
Why?
Medical Records Systems, Computerized
1
1991
66
0.090
Why?
Classification
1
1990
13
0.090
Why?
Medical Errors
1
2012
193
0.090
Why?
Mass Screening
3
2008
662
0.090
Why?
Complement C3b Inactivator Proteins
1
2010
4
0.090
Why?
Family
2
2009
224
0.090
Why?
Boston
2
2011
336
0.090
Why?
Introns
2
2008
106
0.090
Why?
Radiotherapy Dosage
5
2000
82
0.090
Why?
Lipoproteins, HDL
1
2010
36
0.090
Why?
Blood Proteins
1
2010
72
0.090
Why?
Liver Neoplasms
6
1992
279
0.090
Why?
Models, Molecular
1
2014
1137
0.090
Why?
Macular Edema
1
2010
24
0.080
Why?
Scavenger Receptors, Class B
1
2009
3
0.080
Why?
Exons
2
2008
193
0.080
Why?
Lens, Crystalline
1
2009
15
0.080
Why?
Drug Therapy, Combination
2
2008
435
0.080
Why?
Cattle
1
2010
306
0.080
Why?
HLA Antigens
1
2009
60
0.080
Why?
Protein Binding
1
2014
1566
0.080
Why?
Major Histocompatibility Complex
1
2009
87
0.080
Why?
Leukocytes
1
2009
99
0.080
Why?
Membrane Proteins
2
2007
847
0.080
Why?
Sclera
1
1989
12
0.080
Why?
Gene Deletion
1
2010
298
0.080
Why?
Pregnancy Complications, Neoplastic
2
1993
12
0.080
Why?
Reverse Transcriptase Polymerase Chain Reaction
1
2010
525
0.080
Why?
Seafood
1
2008
18
0.080
Why?
Chromosomes, Human, Pair 4
1
2008
17
0.080
Why?
Eyeglasses
1
2008
7
0.080
Why?
Pharmacogenetics
1
2008
21
0.080
Why?
Enzyme-Linked Immunosorbent Assay
1
2009
449
0.080
Why?
ROC Curve
1
2008
260
0.070
Why?
Sex Distribution
2
2009
255
0.070
Why?
Eyelid Neoplasms
3
1986
9
0.070
Why?
Amino Acid Sequence
1
2010
1589
0.070
Why?
Epidemiologic Methods
2
1999
69
0.070
Why?
Evaluation Studies as Topic
6
1992
104
0.070
Why?
Laser Therapy
2
1997
36
0.070
Why?
Estrogens, Conjugated (USP)
1
2006
25
0.070
Why?
Cell Count
2
2016
129
0.070
Why?
Calcium Channels
1
2006
97
0.060
Why?
Ultrasonics
1
1986
16
0.060
Why?
Histocompatibility Antigens Class I
1
2007
132
0.060
Why?
Cryptorchidism
1
1985
9
0.060
Why?
Infant, Newborn
3
2019
1315
0.060
Why?
Chi-Square Distribution
1
2006
406
0.060
Why?
Chromosomes, Human, Pair 20
1
2005
7
0.060
Why?
Chromosomes, Human, Pair 2
1
2005
10
0.060
Why?
Chromosomes, Human, Pair 6
1
2005
16
0.060
Why?
Lipoprotein(a)
1
2005
9
0.060
Why?
Vascular Cell Adhesion Molecule-1
1
2005
15
0.060
Why?
Chromosomes, Human, Pair 19
1
2005
17
0.060
Why?
Chromosomes, Human, Pair 1
1
2005
24
0.060
Why?
Progesterone
1
2006
157
0.060
Why?
Receptors, Tumor Necrosis Factor, Type II
1
2005
30
0.060
Why?
Intercellular Adhesion Molecule-1
1
2005
53
0.060
Why?
Elastin
1
2025
10
0.060
Why?
Recombination, Genetic
1
2006
237
0.060
Why?
Eye Injuries
3
1991
14
0.060
Why?
Intracellular Signaling Peptides and Proteins
1
2007
325
0.060
Why?
Breast Neoplasms
1
2014
1132
0.060
Why?
Skull Neoplasms
1
1985
7
0.060
Why?
Scandinavian and Nordic Countries
1
2004
4
0.060
Why?
Neoplasms, Multiple Primary
3
2014
29
0.060
Why?
Laminin
1
2025
76
0.060
Why?
Founder Effect
1
2004
11
0.060
Why?
Population Dynamics
1
2004
18
0.060
Why?
Physicians
4
1994
442
0.060
Why?
Collagen
1
2025
119
0.060
Why?
Cause of Death
2
2019
205
0.060
Why?
Glycemic Index
1
2004
25
0.060
Why?
Evidence-Based Medicine
1
2007
457
0.060
Why?
Dietary Carbohydrates
1
2004
76
0.060
Why?
Species Specificity
1
2004
335
0.060
Why?
Cricetinae
4
2021
376
0.060
Why?
Diagnosis-Related Groups
1
2004
87
0.050
Why?
Hyperglycemia
1
2004
104
0.050
Why?
Fruit
1
2004
124
0.050
Why?
Light Coagulation
3
1996
5
0.050
Why?
Diet Surveys
4
2008
78
0.050
Why?
Age Distribution
1
2004
262
0.050
Why?
Statistics, Nonparametric
1
2003
209
0.050
Why?
Neoplasms, Hormone-Dependent
1
1982
8
0.050
Why?
National Institutes of Health (U.S.)
1
2003
113
0.050
Why?
Conjunctival Neoplasms
1
1982
1
0.050
Why?
Data Collection
3
1994
383
0.050
Why?
Plasmacytoma
1
1982
9
0.050
Why?
Ophthalmologic Surgical Procedures
3
1988
9
0.050
Why?
Retinal Detachment
4
1990
18
0.050
Why?
Receptors, Estrogen
1
1982
125
0.050
Why?
Dose-Response Relationship, Radiation
3
2014
54
0.050
Why?
Neoplasm Recurrence, Local
4
1992
302
0.050
Why?
Contact Lenses, Extended-Wear
3
1991
3
0.050
Why?
Contact Lenses, Hydrophilic
3
1991
6
0.050
Why?
Fatty Acids, Monounsaturated
1
2001
17
0.050
Why?
Linoleic Acid
1
2001
18
0.050
Why?
Complement Membrane Attack Complex
1
2021
5
0.050
Why?
Fatty Acids, Unsaturated
1
2001
34
0.050
Why?
Brain Neoplasms
1
1985
306
0.050
Why?
Guinea Pigs
1
2021
103
0.050
Why?
Hemolysis
1
2021
38
0.050
Why?
Polymerization
1
2021
35
0.050
Why?
alpha-Linolenic Acid
1
2001
5
0.050
Why?
Cricetulus
1
2021
102
0.050
Why?
beta Carotene
5
2003
67
0.050
Why?
CHO Cells
1
2021
190
0.050
Why?
Sheep
1
2021
168
0.050
Why?
Optometry
1
2000
8
0.050
Why?
Diabetes Complications
4
2007
102
0.050
Why?
Occupational Therapy
1
2000
12
0.050
Why?
Adipose Tissue
1
2003
284
0.040
Why?
Health Status
3
1999
451
0.040
Why?
Macrophages, Peritoneal
1
2000
73
0.040
Why?
Hydrocortisone
1
1981
188
0.040
Why?
Mice, Knockout
1
2025
1999
0.040
Why?
Twin Studies as Topic
1
1999
15
0.040
Why?
Health Personnel
2
2001
343
0.040
Why?
Keratitis
2
1989
9
0.040
Why?
Eye
3
1989
54
0.040
Why?
New England
5
1991
268
0.040
Why?
Radiotherapy, High-Energy
3
1989
8
0.040
Why?
Retinal Perforations
1
1999
8
0.040
Why?
Zeaxanthins
3
2007
16
0.040
Why?
Xanthophylls
3
2007
24
0.040
Why?
History, 21st Century
1
2019
166
0.040
Why?
History, 20th Century
1
2019
230
0.040
Why?
Neoplasm Metastasis
3
1991
196
0.040
Why?
Terminology as Topic
1
1999
138
0.040
Why?
Retinal Vein Occlusion
1
1998
18
0.040
Why?
Sex Factors
5
2011
969
0.040
Why?
Health Services Research
1
1999
270
0.040
Why?
Mice, Inbred C57BL
1
2025
3218
0.040
Why?
Genetic Heterogeneity
1
1997
23
0.040
Why?
Research
1
1999
190
0.040
Why?
Lung Neoplasms
3
2000
577
0.040
Why?
Ethanol
1
2000
307
0.030
Why?
Corneal Ulcer
3
1991
3
0.030
Why?
Epidemiologic Studies
1
2016
36
0.030
Why?
Smoking Cessation
1
2002
538
0.030
Why?
Vision Screening
2
1993
8
0.030
Why?
Photoreceptor Cells, Vertebrate
1
2016
13
0.030
Why?
Epithelium
2
1987
97
0.030
Why?
Codon, Nonsense
1
2015
51
0.030
Why?
Docosahexaenoic Acids
2
2008
31
0.030
Why?
Statistics as Topic
3
1997
147
0.030
Why?
Triethylenemelamine
1
2014
1
0.030
Why?
Radiation Dosage
2
2009
130
0.030
Why?
Astrocytes
1
2015
116
0.030
Why?
Antineoplastic Agents, Alkylating
1
2014
31
0.030
Why?
Genes, Retinoblastoma
1
2014
4
0.030
Why?
Self Disclosure
1
1994
37
0.030
Why?
Breast Neoplasms, Male
1
2014
14
0.030
Why?
Sample Size
1
2014
59
0.030
Why?
Single-Blind Method
1
2014
136
0.030
Why?
Cyclotrons
1
1993
3
0.030
Why?
Fatty Acids
2
2001
194
0.030
Why?
Attitude to Health
1
1996
280
0.030
Why?
Mice
2
2025
10343
0.030
Why?
Contraceptives, Oral
1
1993
25
0.030
Why?
Mental Status Schedule
1
1993
18
0.030
Why?
Biopsy
2
1992
376
0.030
Why?
Random Allocation
2
1991
197
0.030
Why?
Multicenter Studies as Topic
2
1990
121
0.030
Why?
Fibrosis
1
1993
152
0.030
Why?
Uveitis
1
1993
32
0.030
Why?
Data Interpretation, Statistical
2
1991
197
0.030
Why?
Accidental Falls
2
1993
154
0.030
Why?
Meta-Analysis as Topic
1
2013
77
0.030
Why?
Postal Service
1
1992
6
0.030
Why?
Maryland
1
2012
33
0.020
Why?
Complement Factor D
1
2011
4
0.020
Why?
Hand
1
1992
66
0.020
Why?
Actuarial Analysis
3
1988
16
0.020
Why?
Cell Nucleolus
3
1987
68
0.020
Why?
Gene Dosage
1
2011
60
0.020
Why?
Genomics
1
2014
314
0.020
Why?
Cognition Disorders
1
1993
219
0.020
Why?
Exudates and Transudates
2
1988
11
0.020
Why?
Forms and Records Control
1
1991
12
0.020
Why?
Aphakia, Postcataract
1
1991
1
0.020
Why?
Contact Lenses
1
1991
1
0.020
Why?
Placebos
1
1991
71
0.020
Why?
Quality Control
1
1991
70
0.020
Why?
Altitude
1
1990
14
0.020
Why?
Postoperative Care
2
2008
114
0.020
Why?
Sunlight
1
1990
29
0.020
Why?
Personality
1
1990
25
0.020
Why?
Particle Accelerators
2
1989
6
0.020
Why?
Longevity
1
2011
112
0.020
Why?
Radon
1
2009
2
0.020
Why?
Radiation, Ionizing
1
2009
16
0.020
Why?
Elastic Tissue
1
1989
5
0.020
Why?
Diabetic Retinopathy
1
2010
45
0.020
Why?
Occupational Exposure
1
1992
310
0.020
Why?
Delivery of Health Care
1
1994
424
0.020
Why?
Poisson Distribution
1
2009
52
0.020
Why?
Compliance
1
1989
5
0.020
Why?
Analysis of Variance
1
1990
577
0.020
Why?
Carcinoma, Squamous Cell
3
1989
239
0.020
Why?
Socioeconomic Factors
1
1991
792
0.020
Why?
Dose-Response Relationship, Drug
1
1991
807
0.020
Why?
Magnetic Resonance Imaging
2
2008
2049
0.020
Why?
Linear Models
2
2004
422
0.020
Why?
Eicosapentaenoic Acid
1
2008
17
0.020
Why?
Atrophy
1
2008
68
0.020
Why?
Phosphorus
1
1988
18
0.020
Why?
Phosphatidylcholines
1
1988
35
0.020
Why?
Interviews as Topic
1
1990
495
0.020
Why?
Lipid Bilayers
1
1988
50
0.020
Why?
Health Status Indicators
1
2008
97
0.020
Why?
Carcinoma, Basal Cell
2
1989
61
0.020
Why?
Lipid Metabolism
1
2009
203
0.020
Why?
Liposomes
1
1988
100
0.020
Why?
Developing Countries
1
2008
84
0.020
Why?
Randomized Controlled Trials as Topic
2
2006
685
0.020
Why?
Adenomatous Polyposis Coli
1
1987
8
0.020
Why?
Image Interpretation, Computer-Assisted
1
2008
167
0.020
Why?
Radiotherapy, Adjuvant
1
2007
61
0.020
Why?
SEER Program
1
2007
68
0.020
Why?
Calcium Channel Blockers
1
2007
56
0.020
Why?
Chemotherapy, Adjuvant
1
2007
77
0.020
Why?
Visual Fields
2
2000
43
0.020
Why?
Helium
1
1986
7
0.020
Why?
Electrocoagulation
1
1986
13
0.020
Why?
Cryosurgery
1
1986
24
0.020
Why?
Hyperthermia, Induced
1
1985
19
0.020
Why?
Image Processing, Computer-Assisted
1
1989
639
0.020
Why?
Estrogens
1
2006
113
0.020
Why?
Nasal Cavity
1
2005
10
0.020
Why?
Cytological Techniques
1
1985
23
0.020
Why?
Carcinoma, Hepatocellular
1
1987
169
0.020
Why?
Urology
1
1985
28
0.020
Why?
Energy Transfer
1
1985
9
0.020
Why?
Spinal Cord Neoplasms
1
1985
9
0.020
Why?
Chondrosarcoma
1
1985
6
0.020
Why?
Chordoma
1
1985
6
0.020
Why?
Nose Neoplasms
1
2005
17
0.020
Why?
Liver Diseases
1
1985
136
0.010
Why?
Glioma
1
1985
102
0.010
Why?
Hepatectomy
1
1984
59
0.010
Why?
Family Practice
1
1985
206
0.010
Why?
Irritants
1
1983
5
0.010
Why?
Antineoplastic Combined Chemotherapy Protocols
1
2007
405
0.010
Why?
Neoplasms
2
1992
1261
0.010
Why?
Confidence Intervals
2
1994
257
0.010
Why?
Risk Reduction Behavior
1
2003
125
0.010
Why?
Factor Analysis, Statistical
2
1993
105
0.010
Why?
Pediatrics
1
1985
268
0.010
Why?
Orbital Neoplasms
1
1982
6
0.010
Why?
Polymorphism, Restriction Fragment Length
1
2001
28
0.010
Why?
Palliative Care
1
1984
215
0.010
Why?
Pregnancy
2
1993
2367
0.010
Why?
DNA Primers
1
2001
293
0.010
Why?
Fishes
1
2001
24
0.010
Why?
Carcinoma, Small Cell
1
2000
21
0.010
Why?
Tomography, X-Ray Computed
1
2008
1481
0.010
Why?
Microsomes
1
2000
11
0.010
Why?
Tobacco Use Disorder
1
1983
245
0.010
Why?
Cell Fractionation
1
2000
31
0.010
Why?
Clinical Trials as Topic
1
2003
443
0.010
Why?
Golgi Apparatus
1
2000
65
0.010
Why?
Glycosylation
1
2000
135
0.010
Why?
N-Acetylneuraminic Acid
1
2000
53
0.010
Why?
Rats, Wistar
1
2000
179
0.010
Why?
Brassica
1
1999
7
0.010
Why?
Spinacia oleracea
1
1999
11
0.010
Why?
Light
1
2000
201
0.010
Why?
Remission, Spontaneous
1
1999
13
0.010
Why?
Carcinoma, Non-Small-Cell Lung
1
2000
147
0.010
Why?
Stress, Psychological
1
1983
451
0.010
Why?
Blood Pressure
1
1981
522
0.010
Why?
Ion Channels
1
1999
88
0.010
Why?
Internship and Residency
1
1985
747
0.010
Why?
Frameshift Mutation
1
1997
29
0.010
Why?
Sequence Deletion
1
1997
114
0.010
Why?
Rats
1
2000
1918
0.010
Why?
Cells, Cultured
1
2000
2101
0.010
Why?
Mesocricetus
2
1985
93
0.010
Why?
Vision, Ocular
1
1995
17
0.010
Why?
Postoperative Complications
2
1992
1172
0.010
Why?
Lenses, Intraocular
1
1994
5
0.010
Why?
Outpatient Clinics, Hospital
1
1993
40
0.010
Why?
Distance Perception
1
1992
2
0.010
Why?
Occupations
1
1993
52
0.010
Why?
Hyperplasia
1
1992
85
0.010
Why?
Platelet Aggregation Inhibitors
1
1994
218
0.010
Why?
Telephone
1
1992
121
0.010
Why?
Educational Status
1
1993
273
0.010
Why?
Automobile Driving
1
1992
56
0.010
Why?
Necrosis
1
1992
140
0.010
Why?
Ophthalmic Solutions
1
1991
12
0.010
Why?
Craniocerebral Trauma
1
1991
57
0.010
Why?
Selection Bias
1
1990
24
0.010
Why?
Psychometrics
1
1992
359
0.010
Why?
Mitosis
1
1992
210
0.010
Why?
Hypnotics and Sedatives
1
1991
74
0.010
Why?
Wounds, Nonpenetrating
1
1991
103
0.010
Why?
Depressive Disorder
1
1993
292
0.010
Why?
Accidents, Traffic
1
1991
151
0.010
Why?
Carcinoma, Merkel Cell
1
1989
8
0.010
Why?
Alcoholism
1
1993
308
0.010
Why?
Cardiovascular Agents
1
1991
101
0.010
Why?
Glaucoma, Neovascular
1
1989
2
0.010
Why?
Hygiene
1
1989
11
0.010
Why?
Chronic Disease
1
1993
745
0.010
Why?
Comorbidity
1
1993
1098
0.010
Why?
Remission Induction
1
1989
139
0.010
Why?
Histological Techniques
1
1988
18
0.000
Why?
Palmitic Acids
1
1988
3
0.000
Why?
Myristic Acids
1
1988
5
0.000
Why?
Myristic Acid
1
1988
9
0.000
Why?
Palmitic Acid
1
1988
13
0.000
Why?
Stearic Acids
1
1988
9
0.000
Why?
Spectrophotometry
1
1988
32
0.000
Why?
Electrochemistry
1
1988
27
0.000
Why?
Hyphema
1
1988
3
0.000
Why?
Chemistry
1
1988
30
0.000
Why?
Eye Foreign Bodies
1
1988
8
0.000
Why?
Osmolar Concentration
1
1988
89
0.000
Why?
Probability
1
1988
173
0.000
Why?
Chemical Phenomena
1
1988
93
0.000
Why?
Colloids
1
1988
51
0.000
Why?
Pigmentation
1
1988
25
0.000
Why?
Retinal Hemorrhage
1
1987
8
0.000
Why?
Sodium
1
1987
61
0.000
Why?
Iris Diseases
1
1987
2
0.000
Why?
Risk-Taking
1
1988
159
0.000
Why?
Ultrasonography
1
1989
460
0.000
Why?
Athletic Injuries
1
1988
72
0.000
Why?
Temperature
1
1988
299
0.000
Why?
Hydrogen-Ion Concentration
1
1988
434
0.000
Why?
Ultrasonic Therapy
1
1985
9
0.000
Why?
Carbon Tetrachloride
1
1985
9
0.000
Why?
Occupational Diseases
1
1988
266
0.000
Why?
Hematoxylin
1
1985
11
0.000
Why?
Eosine Yellowish-(YS)
1
1985
12
0.000
Why?
Neoplasm Transplantation
1
1985
160
0.000
Why?
In Vitro Techniques
1
1986
472
0.000
Why?
Computers
1
1985
48
0.000
Why?
Chemical and Drug Induced Liver Injury
1
1985
41
0.000
Why?
Methods
1
1985
38
0.000
Why?
Rabbits
1
1985
331
0.000
Why?
Neoplasm Invasiveness
1
1985
248
0.000
Why?
Combined Modality Therapy
1
1985
361
0.000
Why?
Preoperative Care
1
1985
177
0.000
Why?
Lacrimal Apparatus Diseases
1
1982
1
0.000
Why?
Dermoid Cyst
1
1982
3
0.000
Why?
Epidermal Cyst
1
1982
10
0.000
Why?
Fibroma
1
1982
12
0.000
Why?
Hemangioma
1
1982
28
0.000
Why?
China
1
1982
141
0.000
Why?
Carcinoma
1
1982
117
0.000
Why?
Seddon's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (703)
Explore
_
Co-Authors (2)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_
Physical Neighbors
_